Long
Will Shockwave Medical bounce on Earnings tonight?
Shockwave is a medical device company focused around catheters as implantable medical devices to help assist in treating cardiovascular disease.
It has had a strong run trending nicely since March last year and is up around 500%+ since then or up over 250% over just the last 12 months - both numbers including the big pullback.
It will be interesting to see if todays numbers come in well. One way to trade it might be to set a stop order a few percent above its current price to capture it if it heads in the right direction.
Worth a look.
It was at $86 when I started to look at it last year.
It has had a strong run trending nicely since March last year and is up around 500%+ since then or up over 250% over just the last 12 months - both numbers including the big pullback.
It will be interesting to see if todays numbers come in well. One way to trade it might be to set a stop order a few percent above its current price to capture it if it heads in the right direction.
Worth a look.
It was at $86 when I started to look at it last year.
Note
Nice 23% run so far.
NOT TRADING ADVICE. ALWAYS DO YOUR OWN RESEARCH.
MY SITES:
FIND TRENDING STOCKS: HigherHighs.com/
FIND AND SET TRAILING STOPS: SuperTrail.io
TRADINGVIEW TIPS: YouTube.com/@zAngus
MY SITES:
FIND TRENDING STOCKS: HigherHighs.com/
FIND AND SET TRAILING STOPS: SuperTrail.io
TRADINGVIEW TIPS: YouTube.com/@zAngus
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
NOT TRADING ADVICE. ALWAYS DO YOUR OWN RESEARCH.
MY SITES:
FIND TRENDING STOCKS: HigherHighs.com/
FIND AND SET TRAILING STOPS: SuperTrail.io
TRADINGVIEW TIPS: YouTube.com/@zAngus
MY SITES:
FIND TRENDING STOCKS: HigherHighs.com/
FIND AND SET TRAILING STOPS: SuperTrail.io
TRADINGVIEW TIPS: YouTube.com/@zAngus
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.